Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk.
He J, Alhamwe BA, Sabroso S, Carrato A, Hidalgo M, Molero X, Iglesias M, Perea J, Farré A, Tardón A, Dominguez-Muñoz E, Barberà V, Muñoz-Bellvís L, Löhr M, Greenhalf W, O'Rorke M, Gress T, Crnogorac-Jurcevic T, Gayà A, Langtry A, Kleeff J, Lawlor R, Real FX, Renz H, Malats N; PanGenEU Study Investigators.
He J, et al.
Int J Cancer. 2025 Aug 1;157(3):468-479. doi: 10.1002/ijc.35397. Epub 2025 Mar 18.
Int J Cancer. 2025.
PMID: 40098454